ProductsResearch & Development

As of March 2017

Brand NameLaunchIndicationsLicensor
1Nobelzin® capsules
Nobelzin® tablets
Apr 2008
Feb 2015
Wilson’s diseaseTeva
2Lunabell® LD
Lunabell® ULD
Jul 2008
Sep 2013
dysmenorrheaJanssen
3Nobelbar®Dec 2008neonatal seizures,
status epilepticus
In-house
4Fostoin®Jan 2012status epilepticus,
prevention of postoperative seizures, etc.
Pfizer
5Gliadel®Jan 2013malignant gliomaEisai
6Alabel®Sep 2013diagnosis of malignant gliomaSBI Pharmaceuticals (medac)
7Indacin®Jan 2013patent ductus arteriosus of prematurityLundbeck
8Cosmegen®Jan 2013Wilms’ tumor,
choriocarcinoma,
pediatric solid malignant tumor, etc.
Lundbeck
9Unitalc®Dec 2013prevention of recurrent malignant pleural effusionNovatech
10Respia®Dec 2014apnea of prematurityNippon Boehringer
11Rapalimus®Dec 2014lymphangioleiomyomatosisPfizer
12Zanosar®Feb 2015gastroenteropancreatic neuroendocrine tumor Keocyt
13Nobelzin® tabletsMar 2017HypozincemiaIn-house
Page top